To date, no effective treatment is available to alleviate symptoms of AD, such as extracellular deposits of β-amyloid plaques (Aβ) and hyperphosphorylated tau protein, as two main hallmarks of AD, and reduced synaptic plasticity and neurogenesis [3]. Here, MAPT is linked to Alzheimer disease.